Emerging prognostic markers related to mesenchymal characteristics of poorly differentiated breast cancers

被引:66
|
作者
Scimeca, Manuel [1 ,2 ]
Antonacci, Chiara [1 ,2 ]
Colombo, Daniele [1 ]
Bonfiglio, Rita [1 ]
Buonomo, Oreste Claudio [3 ]
Bonanno, Elena [1 ,2 ]
机构
[1] Univ Roma Tor Vergata, Dept Biomed & Prevent, Anat Pathol Sect, Via Montpellier 1, I-00133 Rome, Italy
[2] Spin Off Univ Tor Vergata, TMALab Srl, Rome, Italy
[3] Univ Roma Tor Vergata, Dept Expt Med & Surg, Via Montpellier 1, I-00133 Rome, Italy
关键词
Breast cancer markers; Epithelial to mesenchymal transition; NF-kB; PTX3; K-RAS; Sonic Hedgehog; NF-KAPPA-B; PANCREATIC-CANCER; SIGNALING PATHWAYS; STEM-CELLS; INFLAMMATION; TRANSITION; PRINCIPLES; THERAPY; STATES; PTX3;
D O I
10.1007/s13277-015-4361-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite the screening program, breast cancer is the commonest cause of cancer death in women in the industrialized world. In this study, we investigate the correlation among poorly differentiated carcinoma, epithelial to mesenchymal transition (EMT) phenomenon, and expression of NF-kB, Sonic Hedgehog (SHH), K-RAS, and PTX3 in breast cancer in 100 breast biopsies. Samples were classified as follows: 30 benign lesions (BL), 30 ductal infiltrating carcinomas low grade (MLG1), and 40 ductal infiltrating carcinomas high grade (MLG3). Expression of vimentin, CD44, beta-catenin, NF-kB, SHH, K-RAS, CD44, and PTX3 was studied by immunohistochemistry. The different rate of cells with vimentin, nuclear beta-catenin, and CD44 expression in MLG3 as compared with MLG1 and BL suggested that the process of de-differentiation of breast cancer cells could be related to the EMT. Our results showed a significant increase in NF-kB signal in MLG3 (2.33 +/- 0.77) with respect to MLG1 (1.26 +/- 0.55) and BL (0.86 +/- 0.52). SHH expression appeared low in BL (1.00 +/- 0.41) and homogenously widespread in MLG1 (1.23 +/- 0.63) and MLG3 (1.56 +/- 0.54). An important increase in K-RAS signal was observed in MLG3 compared to that in BL (2.20 +/- 0.69 vs 0.82 +/- 0.59). As regards PTX3, we observed a strong expression in MLG3 (2.00 +/- 0.78) with respect to BL (0.58 +/- 0.55) and MLG1 (1.53 +/- 0.76). The recurring expression of NF-kB, SHH, K-RAS, and PTX3 in vimentin- and CD44-positive breast cancer cells allows to speculate that breast cells acquire the ability to express these molecules in concomitance to EMT phenomenon.
引用
收藏
页码:5427 / 5435
页数:9
相关论文
共 50 条
  • [11] Clinical characteristics of prognostic factors in poorly differentiated (G3) endometrioid adenocarcinoma in Japan
    Kuwabara, Y
    Susumu, N
    Banno, K
    Hirao, T
    Kawaguchi, M
    Yamagami, W
    Suzuki, N
    Aoki, D
    Nozawa, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (01) : 23 - 27
  • [12] Methylation silencing of ULK2 via epithelial–mesenchymal transition causes transformation to poorly differentiated gastric cancers
    Iori Motoo
    Sohachi Nanjo
    Takayuki Ando
    Satoshi Yamashita
    Toshikazu Ushijima
    Ichiro Yasuda
    Gastric Cancer, 2022, 25 : 325 - 335
  • [13] Prognostic characteristics in breast cancers after hormone replacement therapy
    Magnusson, C
    Holmberg, L
    Norden, T
    Lindgren, A
    Persson, I
    BREAST CANCER RESEARCH AND TREATMENT, 1996, 38 (03) : 325 - 334
  • [14] Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype
    Moyret-Lalle, Caroline
    Grelier, Gael
    Lasset, Christine
    Voirin, Nicolas
    Chabaud, Sylvie
    Treilleux, Isabelle
    Puisieux, Alain
    CANCER RESEARCH, 2010, 70
  • [15] Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype
    Grelier, G.
    Voirin, N.
    Ay, A-S
    Cox, D. G.
    Chabaud, S.
    Treilleux, I.
    Leon-Goddard, S.
    Rimokh, R.
    Mikaelian, I.
    Venoux, C.
    Puisieux, A.
    Lasset, C.
    Moyret-Lalle, C.
    BRITISH JOURNAL OF CANCER, 2009, 101 (04) : 673 - 683
  • [16] Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype
    G Grelier
    N Voirin
    A-S Ay
    D G Cox
    S Chabaud
    I Treilleux
    S Léon-Goddard
    R Rimokh
    I Mikaelian
    C Venoux
    A Puisieux
    C Lasset
    C Moyret-Lalle
    British Journal of Cancer, 2009, 101 : 673 - 683
  • [17] Methylation silencing of ULK2 via epithelial-mesenchymal transition causes transformation to poorly differentiated gastric cancers
    Motoo, Iori
    Nanjo, Sohachi
    Ando, Takayuki
    Yamashita, Satoshi
    Ushijima, Toshikazu
    Yasuda, Ichiro
    GASTRIC CANCER, 2022, 25 (02) : 325 - 335
  • [18] MESENCHYMAL MARKERS IN CIRCULATING TUMOUR CELLS: PROGNOSTIC SIGNIFICANCE IN BREAST CANCER PATIENTS
    Risi, E.
    Raimondi, C.
    Nicolazzo, C.
    Palazzo, A.
    Palleschi, M.
    Pochesci, A.
    Petracca, A.
    Naso, G.
    Cortesi, E.
    Gazzanica, P.
    ANNALS OF ONCOLOGY, 2011, 22 : 42 - 42
  • [19] Prognostic Significance of Mesenchymal-Epithelial Transition in Triple-Negative Breast Cancers
    Gao, Hong-Fei
    Yang, Ci-Qiu
    Cheng, Min-Yi
    Zhu, Teng
    Yang, Mei
    Zhang, Liu-Lu
    Wang, Kun
    CLINICAL BREAST CANCER, 2018, 18 (05) : E961 - E966
  • [20] The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers
    Dorna, Dawid
    Paluszczak, Jaroslaw
    CELLS, 2022, 11 (06)